New HIV biomarker identified; Disrupted micronuclei may help diagnose cancer;

> A new study has identified the protein thrombospondin as an HIV biomarker. Story

> Duke Medicine developed a blood test that relies on 60 co-expressed genes to help predict the success of aspirin treatments for cardiac patients. Story

> Salk Institute scientists believe that disrupted micronuclei could serve as a viable biomarker for a number of cancers. Item

> Switzerland's Debiopharm inked a one-year deal to focus on new biomarker discovery. Story

> Patients with low-IQ autism and intellectual disabilities appear to have DNA markers that suggest their conditions are hereditary. Release